Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2PAW

THE CATALYTIC FRAGMENT OF POLY(ADP-RIBOSE) POLYMERASE

Replaces:  1PAW
Summary for 2PAW
Entry DOI10.2210/pdb2paw/pdb
DescriptorPOLY(ADP-RIBOSE) POLYMERASE (2 entities in total)
Functional Keywordstransferase, glycosyltransferase, nad(+) adp-ribosyltransferase, dna-binding
Biological sourceGallus gallus (chicken)
Cellular locationNucleus: P26446
Total number of polymer chains1
Total formula weight40415.35
Authors
Ruf, A.,Schulz, G.E. (deposition date: 1997-11-25, release date: 1998-05-27, Last modification date: 2024-02-21)
Primary citationRuf, A.,de Murcia, G.,Schulz, G.E.
Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.
Biochemistry, 37:3893-3900, 1998
Cited by
PubMed Abstract: Inhibitors of poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) are of clinical interest because they have potential for improving radiation therapy and chemotherapy of cancer. The refined binding structures of four such inhibitors are reported together with the refined structure of the unligated catalytic fragment of the enzyme. Following their design, all inhibitors bind at the position of the nicotinamide moiety of the substrate NAD+. The observed binding mode suggests inhibitor improvements that avoid other NAD(+)-binding enzymes. Because the binding pocket of NAD+ has been strongly conserved during evolution, the homology with ADP-ribosylating bacterial toxins could be used to extend the bound nicotinamide, which is marked by the inhibitors, to the full NAD+ molecule.
PubMed: 9521710
DOI: 10.1021/bi972383s
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.3 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon